[1]
|
Corlateanu, A., Mendez, Y., Wang, Y., et al. (2020) Chronic Obstructive Pulmonary Disease and Phenotypes: A State- of-the-Art. Pulmonology, 26, 95-100. https://doi.org/10.1016/j.pulmoe.2019.10.006
|
[2]
|
Agusti, A. (2014) The Path to Personalised Medicine in COPD. Thorax, 69, 857-864.
https://doi.org/10.1136/thoraxjnl-2014-205507
|
[3]
|
Stolz, D., Mkorombindo, T., Schumann, D.M., et al. (2022) Towards the Elimination of Chronic Obstructive Pulmonary Disease: A Lancet Commission. Lancet, 400, 921-972. https://doi.org/10.1016/S0140-6736(22)01273-9
|
[4]
|
Jones, P., Miravitlles, M., Van Der Molen, T., et al. (2012) Beyond FEV1 in COPD: A Review of Patient-Reported Outcomes and Their Measurement. International Journal of Chronic Obstructive Pulmonary Disease, 7, 697-709.
https://doi.org/10.2147/COPD.S32675
|
[5]
|
Dournes, G., Laurent, F., Coste, F., et al. (2015) Computed Tomo-graphic Measurement of Airway Remodeling and Emphysema in Advanced Chronic Obstructive Pulmonary Disease. Correlation with Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine, 191, 63-70. https://doi.org/10.1164/rccm.201408-1423OC
|
[6]
|
Bui, D.S., Lodge, C.J., Burgess, J.A., et al. (2018) Childhood Predictors of Lung Function Trajectories and Future COPD Risk: A Prospective Cohort Study from the First to the Sixth Decade of Life. The Lancet Respiratory Medicine, 6, 535-544. https://doi.org/10.1016/S2213-2600(18)30100-0
|
[7]
|
Karakioulaki, M., Papakonstantinou, E. and Stolz, D. (2020) Extracellular Matrix Remodelling in COPD. European Respiratory Review, 29, Article ID: 190124. https://doi.org/10.1183/16000617.0124-2019
|
[8]
|
Mkorombindo, T. and Dransfield, M.T. (2022) Pre-Chronic Obstructive Pulmonary Disease: A Pathophysiologic Process or an Opinion Term? Current Opinion in Pulmonary Med-icine, 28, 109-114.
https://doi.org/10.1097/MCP.0000000000000854
|
[9]
|
Barker, B.L. and Brightling, C.E. (2013) Phenotyping the Heterogeneity of Chronic Obstructive Pulmonary Disease. Clinical Science, 124, 371-387. https://doi.org/10.1042/CS20120340
|
[10]
|
AgustÍ, A., MelÉN, E., Demeo, D.L., et al. (2022) Pathogenesis of Chronic Obstructive Pulmonary Disease: Understanding the Contributions of Gene-Environment Interactions across the Lifespan. The Lancet Respiratory Medicine, 10, 512-524. https://doi.org/10.1016/S2213-2600(21)00555-5
|
[11]
|
Han, M.K., Agusti, A., Calverley, P.M., et al. (2010) Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD. American Journal of Respiratory and Criti-cal Care Medicine, 182, 598-604.
https://doi.org/10.1164/rccm.200912-1843CC
|
[12]
|
Lange, P., Halpin, D.M., O’donnell, D.E., et al. (2016) Diag-nosis, Assessment, and Phenotyping of COPD: Beyond FEV1. International Journal of Chronic Obstructive Pulmonary Disease, 11, 3-12.
https://doi.org/10.2147/COPD.S85976
|
[13]
|
Yousuf, A., Mcauley, H., Elneima, O. and Brightling, C.E. (2021) The Different Phenotypes of COPD. British Medical Bulletin, 137, 82-97. https://doi.org/10.1093/bmb/ldaa043
|
[14]
|
Chong, J., Leung, B. and Poole, P. (2017) Phosphodiesterase 4 Inhibitors for Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, 9, CD002309. https://doi.org/10.1002/14651858.CD002309.pub5
|
[15]
|
Hancock, D.B., Eijgelsheim, M., Wilk, J.B., et al. (2010) Meta-Analyses of Genome-Wide Association Studies Identify Multiple Loci Associated with Pulmonary Function. Na-ture Genetics, 42, 45-52. https://doi.org/10.1038/ng.500
|
[16]
|
Wen, X., Deng, Z., Peng, J., et al. (2023) Character-istics of Inflammatory Phenotypes in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. BMJ Open Respiratory Research, 10, e001454.
https://doi.org/10.1136/bmjresp-2022-001454
|
[17]
|
Park, J., Hobbs, B.D., Crapo, J.D., et al. (2020) Subtyping COPD by Using Visual and Quantitative CT Imaging Features. Chest, 157, 47-60. https://doi.org/10.1016/j.chest.2019.06.015
|
[18]
|
Kim, V. and Criner, G.J. (2013) Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 187, 228-237. https://doi.org/10.1164/rccm.201210-1843CI
|
[19]
|
Bao, H., Jia, G., Cong, S., et al. (2021) Phenotype and Man-agement of Chronic Obstructive Pulmonary Disease Patients in General Population in China: A Nationally Cross-Sectional Study. NPJ Primary Care Respiratory Medicine, 31, Article No. 32. https://doi.org/10.1038/s41533-021-00243-x
|
[20]
|
Phillips, D.B., Elbehairy, A.F., James, M.D., et al. (2022) Im-paired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study. American Journal of Respiratory and Critical Care Medicine, 205, 1391-1402. https://doi.org/10.1164/rccm.202109-2171OC
|
[21]
|
Boutou, A.K., Zafeiridis, A., Pitsiou, G., et al. (2020) Cardio-pulmonary Exercise Testing in Chronic Obstructive Pulmonary Disease: An Update on Its Clinical Value and Applica-tions. Clinical Physiology and Functional Imaging, 40, 197-206. https://doi.org/10.1111/cpf.12627
|
[22]
|
James, M.D., Milne, K.M., Phillips, D.B., et al. (2020) Dyspnea and Exercise Limitation in Mild COPD: The Value of CPET. Frontiers in Medicine, 7, Article 442. https://doi.org/10.3389/fmed.2020.00442
|
[23]
|
Broxterman, R.M., Hoff, J., Wagner, P.D., et al. (2020) Determinants of the Diminished Exercise Capacity in Patients with Chronic Obstructive Pul-monary Disease: Looking Beyond the Lungs. The Journal of Physiology, 598, 599-610.
https://doi.org/10.1113/JP279135
|
[24]
|
Maltais, F., Leblanc, P., Whittom, F., et al. (2000) Oxidative Enzyme Activ-ities of the Vastus Lateralis Muscle and the Functional Status in Patients with COPD. Thorax, 55, 848-853. https://doi.org/10.1136/thorax.55.10.848
|
[25]
|
Stickland, M.K., Neder, J.A., Guenette, J.A., et al. (2022) Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease. Chest, 161, 1505-1516.
https://doi.org/10.1016/j.chest.2022.01.021
|
[26]
|
Glaab, T. and Taube, C. (2022) Practical Guide to Cardiopulmo-nary Exercise Testing in Adults. Respiratory Research, 23, Article No. 9. https://doi.org/10.1186/s12931-021-01895-6
|
[27]
|
中华医学会心血管病学分会, 中国康复医学会心肺预防与康复专业委员会, 中华心血管病杂志编辑委员会. 心肺运动试验临床规范应用中国专家共识[J]. 中华心血管病杂志, 2022, 50(10): 973-986.
|
[28]
|
Palange, P., Ward, S.A., Carlsen, K.H., et al. (2007) Recommendations on the Use of Exercise Testing in Clinical Practice. European Respiratory Journal, 29, 185-209. https://doi.org/10.1183/09031936.00046906
|
[29]
|
Gelinas, J., Harper, M., Sasso, J., et al. (2022) Phenotyping Car-diopulmonary Exercise Limitations in Chronic Obstructive Pulmonary Disease. Frontiers in Physiology, 13, Article 816586. https://doi.org/10.3389/fphys.2022.816586
|
[30]
|
Weber, K.T. and Janicki, J.S. (1985) Cardiopulmonary Exercise Testing for Evaluation of Chronic Cardiac Failure. Am The American Journal of Cardiology, 55, 22A-31A. https://doi.org/10.1016/0002-9149(85)90792-1
|
[31]
|
Caruso, F.R., Goulart, C.D.L., Bonjorno Jr., J.C., et al. (2023) Predictors of Cardiopulmonary Exercise Testing in COPD Patients according to the Weber Classification. Heart & Lung, 62, 95-100.
https://doi.org/10.1016/j.hrtlng.2023.06.022
|